Details for H-B-Vax II (hepatitis B) vaccine and its components. Registered for use from birth. Recombinant hepatitis B vaccine. Adult formulation. Each 1.0 mL monodose vial or pre-filled syringe contains: Paediatric formulation. Each 0.5 mL monodose vial or pre-filled syringe contains: Dialysis formulation. Each 1.0 mL monodose vial contains:

3 天之前 · H-B-VAX II is a vaccine used to help prevent hepatitis B. The vaccine can be given to newborns, infants, children, teenagers and adults.

2018年4月3日 · H-B-Vax II is a vaccine used to help prevent hepatitis B. The vaccine can be given to newborns, infants, children, teenagers and adults. Hepatitis B is an infection of the liver caused by the hepatitis B virus (HBV). It can be caught by coming into contact with an infected person’s blood, semen, vaginal secretions, saliva or other body fluids.

The recommended pediatric and adult dose per injection for Engerix-B is double the dose for RECOMBIVAX HB Vax II. So far, over a billion doses of recombinant vaccines have been administered worldwide, with an excellent record of safety and immunogenicity.

Monovalent hepatitis B vaccines by age of vaccine recipient in years, showing dose, number of doses, recommended minimum intervals between doses, and alternative schedule minimum intervals.

下的新生兒接種三劑5 µg 劑量的h-b-vax ii，已證實可產生保護效果。在一項臨 床研究中，130 位嬰兒於出生時接受一劑的b 型肝炎免疫球蛋白(hbig)，然後再 依建議時間接種三劑的h-b-vax ii，在追蹤九個月之後，有96%並未發生慢性感. b. b. b. b h-b-vax ii b

A low dose of recombinant DNA hepatitis B vaccine (HB-VAX II, MSD) was tested for efficacy in the prevention of perinatal hepatitis B virus (HBV) transmission in normal and high-risk neonates born from HBsAg carrier mothers. A dose of 2.5 micrograms recombinant vaccine was injected intramuscularly a …

2020年10月7日 · H-B-Vax II (hepatitis B vaccine [recombinant], MSD), (5 microgram/0.5 mL [without preservative]) is available for use in individuals for whom a thiomersal-free vaccine is advisable (e.g. infants who may receive other vaccines containing thiomersal).

H-B-Vax II is indicated for immunisation against infection caused by all known subtypes of Hepatitis B virus. Adolescent vaccination is not necessary for children who have received a primary course of hepatitis B vaccine.

Hepatitis B vaccination programs using either Engerix B or Recombivax/HB-Vax II can achieve high seroprotective response rates, particularly in childhood and adolescence. Ideally, younger populations should be a primary target in current universal vaccination programs.